Roflumilast foam 0.3%, a non-steroidal PDE4 inhibitor, has shown significant promise for treating psoriasis in adults and adolescents aged 12 and older....
Managing Psoriasis in Older Patients: Balancing Treatment Efficacy and Increased Risks
Psoriasis treatments for patients of all ages often include topicals, phototherapy, oral agents like methotrexate and cyclosporine, new oral inhibitors,...
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States
LITE Study Shows Home-Based Phototherapy Effective for Psoriasis, Boosts Treatment Adherence
Researchers of the LITE Study demonstrated that home-based phototherapy for psoriasis is non-inferior to office-based phototherapy across all skin types...
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States